Early Course of the Patient with a Kidney Transplant

Kidney Transplantation: Principles and Practice

Volumn , Issue , 2008, Pages 210-219

  Knechtle, Stuart J ^a   Pirsch, John D ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85133741336     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3343-150018-9     Document Type: Chapter

References (59)

1. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993, 55:752.
2. Artero M, Biava C, Amend W, et al. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992, 92:375.
3. Artero ML, Sharma R, Savin VJ, et al. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994, 23:574.
4. Audard V, Matignon M, Hemery F, et al. Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty. Am J Transplant 2006, 6:95.
5. Aultman DF, Sawaya DE, Zibari GB, et al. Are all successful renal transplants really successful?. Am J Kidney Dis 1999, 34:61.
6. Becker BN, Odorico JS, Becker YT, et al. Peripheral vascular disease and renal transplant artery stenosis: a reappraisal of transplant renovascular disease. Clin Transplant 1999, 13:349.
7. Cecka JM The UNOS Scientific Renal Transplant Registry-ten years of kidney transplants. Clinical Transplants 1997 1998, 1-14. UCLA Tissue Typing Laboratory, Los Angeles. J.M. Cecka, P.I. Terasaki (Eds.).
8. Cecka JM The UNOS Scientific Renal Transplant Registry. Clinical Transplants 1998 1999, 1-16. UCLA Tissue Typing Laboratory, Los Angeles. J.M. Cecka, P.I. Terasaki (Eds.).
9. Cecka JM The UNOS Renal Transplant Registry. Clinical Transplants 2002 2003, 1-20. UCLA Immunogenetics Center, Los Angeles. J.M. Cecka, P.I. Terasaki (Eds.).
10. Cecka JM The OPTN/UNOS Renal Transplant Registry. Clinical Transplants 2004 2005, 1-16. UCLA Immunogenetics Center, Los Angeles. J.M. Cecka, P.I. Terasaki (Eds.).
11. Chiurchiu C, Ruggenenti P, Remuzzi G Thrombotic microangiopathy in renal transplantation. Ann Transplant 2002, 7:28.
12. Cho YW Expanded criteria donors. Clinical Transplants 1998 1999, 421-436. UCLA Tissue Typing Laboratory, Los Angeles. J.M. Cecka, P.I. Terasaki (Eds.).
13. Curtis JJ Hypertension following kidney transplantation. Am J Kidney Dis 1994, 23:471.
14. Curtis JJ Management of hypertension after transplantation. Kidney Int 1993, 43(Suppl):S45.
15. Dawidson I, Rooth P, Alway C, et al. Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity. Transplant Proc 1990, 22:1379.
16. Dawidson I, Rooth P, Fry WR, et al. Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil. Transplantation 1989, 48:575.
17. Dawidson IJ, Sandor ZF, Coorpender L, et al. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation 1992, 53:774.
18. del Pizzo JJ, Jacobs SC, Bartlett ST, et al. The use of bladder for total transplant ureteral reconstruction. J Urol 1998, 159:750.
19. Dempsey CM, Lim MS, Stacey SG A prospective audit of blood loss and blood transfusion in patients undergoing coronary artery bypass grafting after clopidogrel and aspirin therapy. Crit Care Resusc 2004, 6:248.
20. Erturk E, Burzon DT, Waldman D Treatment of transplant ureteral stenosis with endoureterotomy. J Urol 1999, 161:412.
21. Fervenza FC, Lafayette RA, Alfrey EJ, et al. Renal artery stenosis in kidney transplants. Am J Kidney Dis 1998, 31:142.
22. First MR, Neylan JF, Rocher LL, et al. Hypertension after renal transplantation. J Am Soc Nephrol 1994, 4(8 Suppl):S30.
23. Fuggle SV, Koo DD Cell adhesion molecules in clinical renal transplantation. Transplantation 1998, 65:763.
24. Ghasemian SMR, Guleria AS, Khawand NY, et al. Diagnosis and management of the urologic complications of renal transplantation. Clin Transplant 1996, 10:218.
25. Hanto DW, Brunt EM, Goss JA, et al. Accelerated acute rejection of an A2 renal allograft in an O recipient: association with an increase in anti-A2 antibodies. Transplantation 1993, 56:1580.
26. Jordan SC, Vo AA, Tyan D, et al. Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant 2005, 9:408.
27. Kaplan AA Therapeutic apheresis for renal disorders. Ther Apher 1999, 3:25.
28. Knechtle SJ Ureteroneocystostomy for renal transplantation. J Am Coll Surg 1999, 188:707.
29. Kristo B, Phelan MW, Gritsch HA, et al. Treatment of renal transplant ureterovesical anastomotic strictures using antegrade balloon dilation with or without holmium: YAG laser endoureterotomy. Urology 2003, 62:831.
30. Lake KD, Canafax DM Important interactions of drugs with immuno-suppressive agents used in transplant recipients. J Antimicrob Chemother 1995, 36(Suppl B):11.
31. Land W Postischemic reperfusion injury and kidney transplantation: prologue. Transplant Proc 1998, 30:4210.
32. Mason J Renal side-effects of cyclosporine. Transplant Proc 1990, 22:1280.
33. Metzger RA, Delmonico FL, Feng S, et al. Expanded criteria donors for kidney transplantation. Am J Transplant 2003, 3(Suppl 4):114.
34. Morris PJ, Russell NK Alemtuzumab (Campath-1H): a systematic review in organ transplantation. Transplantation 2006, 81:1361.
35. Nampoory MR, Khan ZU, Johny KV, et al. Invasive fungal infections in renal transplant recipients. J Infect 1996, 33:95.
36. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003, 349:2326.
37. Newell KA, Millis JM, Arnow PM, et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998, 65:439.
38. Orloff SL, Busch AM, Olyaei AJ, et al. Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg 1999, 177:418.
39. Oyen O, Strom EH, Midtvedt K, et al. Calcineurin inhibitor-free immuno-suppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome. Am J Transplant 2006, 6:412.
40. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996, 23:760.
41. Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004, 4:611.
42. Paya CV Fungal infections in solid-organ transplantation. Clin Infect Dis 1993, 16:677.
43. Penny MJ, Nankivell BJ, Disney AP, et al. Renal graft thrombosis: a survey of 134 consecutive cases. Transplantation 1994, 58:565.
44. Perico N, Ruggenenti P, Gaspari F, et al. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992, 54:56.
45. Pirsch JD, Friedman R Primary care of the renal transplant patient. J Gen Intern Med 1994, 9:29.
46. Pirsch JD, Odorico JS, D'Alessandro AM, et al. Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. Transplantation 1998, 66:1746.
47. Racusen LC, Haas M Antibody-mediated rejection in renal allografts: lessons from pathology. Clin J Am Soc Nephrol 2006, 1:415.
48. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713.
49. Rubin RH Infectious diseases in transplantation/pre- and post-transplantation. Primer on Transplantation 1998, 141-152. American Society of Transplant Physicians, Thorofare, NJ. D.J. Norman, W.N. Suki (Eds.).
50. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996, 334:878.
51. Shames BD, Odorico JS, D'Alessandro AM, et al. Surgical repair of transplant renal artery stenosis with preserved cadaveric iliac artery grafts. Ann Surg 2003, 237:116.
52. Shoskes DA, Cecka JM Effect of delayed graft function on short- and long-term kidney graft survival. Clinical Transplants 1997 1998, 297. UCLA Tissue Typing Laboratory, Los Angeles. J.M. Cecka, P.I. Terasaki (Eds.).
53. Singh A, Stablein D, Tejani A Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997, 63:1263.
54. Solez K, Vincenti F, Filo RS Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998, 66:1736.
55. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation: a multivariate analysis. Transplantation 1995, 59:962.
56. Trotter JF Drugs that interact with immunosuppressive agents. Semin Gastrointest Dis 1998, 9:147.
57. Wong W, Fynn SP, Higgins RM, et al. Transplant renal artery stenosis in 77 patients-does it have an immunological cause?. Transplantation 1996, 61:215.
58. Woo YM, Jardine AG, Clark AF, et al. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 1999, 55:692.
59. Zeier M, Mandelbaum A, Ritz E Hypertension in the transplanted patient. Nephron 1998, 80:257.